Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
QLT CMO steps down
Dipak Panigrahi, MD, senior vice president, research and development, and chief medical officer of QLT has stepped down from his position with QLT.
Vancouver, Canada-Dipak Panigrahi, MD, senior vice president, research and development, and chief medical officer of QLT has stepped down from his position.
Suzanne Cadden, QLT’s vice president, Regulatory Affairs, and Anthony Pepio, executive director, Ophthalmology Development have assumed research and development and product portfolio responsibilities. Cadden also assumed overall responsibility for clinical operations at QLT, and Pepio will lead preclinical and formulations development.
Related Videos
Related Content
